These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Banning ephedra: good call, poor vision. Gordon JS Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346 [No Abstract] [Full Text] [Related]
4. Hazards of hindsight--monitoring the safety of nutritional supplements. Cohen PA N Engl J Med; 2014 Apr; 370(14):1277-80. PubMed ID: 24693886 [No Abstract] [Full Text] [Related]
5. Drug-induced liver injury: an overview over the most critical compounds. Björnsson ES Arch Toxicol; 2015 Mar; 89(3):327-34. PubMed ID: 25618544 [TBL] [Abstract][Full Text] [Related]
6. [Hepatotoxicity of dietary supplements and herbals is mostly unknown]. Jacobsen C; Semb S; Kromann-Andersen H Ugeskr Laeger; 2011 Aug; 173(34):2030-4. PubMed ID: 21867654 [TBL] [Abstract][Full Text] [Related]
7. HERBALIFE® ASSOCIATED SEVERE HEPATOTOXICITY IN A PREVIOUSLY HEALTHY WOMAN. Jurčić D; Gabrić M; Troskot Perić R; Liberati Pršo AM; Mirat J; Včev A; Alerić I; Ebling B Acta Clin Croat; 2019 Dec; 58(4):771-776. PubMed ID: 32595263 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacovigilance and herbal hepatotoxicity: critical aspects and solutions]. Teschke R; Schulze J Dtsch Med Wochenschr; 2013 Feb; 138(6):281-4. PubMed ID: 23361353 [TBL] [Abstract][Full Text] [Related]
10. Psychiatric symptoms associated with ephedra use. Maglione M; Miotto K; Iguchi M; Hilton L; Shekelle P Expert Opin Drug Saf; 2005 Sep; 4(5):879-84. PubMed ID: 16111450 [TBL] [Abstract][Full Text] [Related]
11. Time to ban ephedra--now. Guharoy R; Noviasky JA Am J Health Syst Pharm; 2003 Aug; 60(15):1580-2. PubMed ID: 12951759 [No Abstract] [Full Text] [Related]
13. NEJM study detailing the causative link between ephedra-containing supplements and adverse cardiovascular and neurovascular. Wolf L; Wolf M; Snavely M; Staudenmeier JJ; Mil Med; 2002 Sep; 167(9):ii. PubMed ID: 12363175 [No Abstract] [Full Text] [Related]
14. [Drug-induced liver injury from the dietary supplement Fortodol. A manipulated preparation delayed the diagnosis]. Kechagias S; Hägg S; Lotfi K Lakartidningen; 2010 Jan 27-Feb 2; 107(4):186-8. PubMed ID: 20333973 [No Abstract] [Full Text] [Related]
16. Addressing the potential risks associated with ephedra use: a review of recent efforts. Schulman S Public Health Rep; 2003; 118(6):487-92. PubMed ID: 14563905 [TBL] [Abstract][Full Text] [Related]